Allena Pharmaceuticals

-$0.04 (-3.51%) Today
+$0.01 (+0.91%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ALNA and other stocks, options, and ETFs commission-free!

About ALNA

Allena Pharmaceuticals, Inc. engages in the development, discovery and commercialization of oral enzyme therapeutics to treat patients with kidney disorders. Its product pipeline includes reloxaliase, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria in adults and ALLN-346, which is used for patients with hyperuricemia and moderate to severe chronic kidney disease.

CEO
Louis Brenner
Employees
41
Headquarters
Newton, Massachusetts
Founded
2011

ALNA Key Statistics

Market Cap
64.49M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
810.09K
High Today
$1.15
Low Today
$1.10
Open Price
$1.12
Volume
398.00K
52 Week High
$3.39
52 Week Low
$1.02

ALNA Earnings

-$0.57
-$0.38
-$0.19
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.23 per share
Actual
-$0.21 per share

You May Also Like

CLRMU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure